Douglas A. Dachille, Director at BridgeBio Pharma, Inc. (BBIO), bought 10,000 shares at $16.82 ($164K) on 2022-01-04, disclosed to the SEC on 2022-01-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.82 | 5,000 | $84K | 51.4% |
| 2 | $15.91 | 5,000 | $80K | 48.6% |
| Total | $16.36 avg | 10,000 | $164K | 100% |
| Filing → |
| AIG | SELL | 2021-06-04 | $2.1M | — | Filing → |